New Research on the Global Generic Drugs Market | Technavio

Technavio has published a new market research report on the global generic drugs market from 2018-2022.

LONDON--()--Market research firm Technavio has announced the release of their latest report on the global generic drugs market. This new report will provide expert market insights for the forecast period 2018-2022.

The report will follow up on Technavio’s previous generic drugs research, offering an up-to-date analysis of the market concerning the current market scenario, latest trends and drivers, and the overall global environment.

The upgraded research report on the generic drugs market is an integral part of Technavio’s cardiovascular and metabolic disorders portfolio. Technavio covers an extensive range of market research reports on the cardiovascular and metabolic disorders market, covering different regions and top industry segments. Some of the topics include inflammatory bowel disease, liver cirrhosis therapeutics, type 1 diabetes drugs, age-related macular degeneration, and rheumatoid arthritis drugs.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

Opportunities for growth in the market

Technavio’s previous report on the global generic drugs market projected that the Americas showed the highest potential with a market share of nearly 41% in 2016 when compared to APAC and EMEA. In the Americas, the growth of the market is attributed to the increasing number of people with chronic illness and the patent expiries of top-selling drugs. Countries such as the US is the highest revenue contributor in this region. Even though the market in the US is saturating, it is likely to remain the largest generic drugs market in terms of value owing to the region's higher profit margins and legislation that enables the growth of generic drugs. This is expected to drive the US generic drug market size during the forecast period.

In the previous report, a senior research analyst at Technavio stated, “Most of the pharmaceutical companies are increasing their focus on outsourcing as a business strategy as they have been experiencing a decline in venture capital investment. While some of the players are looking to outsource parts of their R&D process, such as product characterization testing and toxicology testing to contract organizations, the others are encouraged to outsource parts or even their entire manufacturing processes to other organizations. This emerging trend of outsourcing helps pharmaceutical companies cut down on costs, which will drive the generic drugs market growth in the future.”

Technavio’s new on the report on the global generic drugs market will evaluate the key geographical regions and their behavior over the past four years, introducing new data and observations and providing new predictions.

Looking for the latest information on the global generic drugs market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Detailed analysis at your fingertips

Some of the topics that will be revisited in the new report include:

  • Market size and growth rate through 2022
  • Top factors driving the market growth
  • Market opportunities and factors impeding growth
  • Market share analysis of the key players

The report on the global generic drugs market for the period 2018-2022 is available to order now and will be delivered within one week of purchase.


Save big with Technavio this May!

Find out what companies are venturing in to beat the heat this summer! Technavio indulges you with a massive 20% OFF on all

non-alcoholic beverages reports for the entire month.


Technavio honors the achievements and efforts of Motherhood this Mother's Day by offering a whopping 30% OFF on all cosmetics and toiletry reports. Offer valid from 7th May for a limited period.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

Market research firm Technavio has announced the release of their latest report on the global generic drugs market for 2018-2022.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200